matrix-assisted laser desorption/ionization time of flight mass spectrometry (maldi-tof ms) platform massarray tm (Sequenom)
90
Structured Review
Sequenom
matrix-assisted laser desorption/ionization time of flight mass spectrometry (maldi-tof ms) platform massarray tm
Matrix Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry (Maldi Tof Ms) Platform Massarray Tm, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray%C2%AE+maldi-tof+platform/sequenom+massarray/pmc12272062-138-11-19
Average 90 stars, based on 1 article reviews
Matrix Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry (Maldi Tof Ms) Platform Massarray Tm, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray%C2%AE+maldi-tof+platform/sequenom+massarray/pmc12272062-138-11-19
Average 90 stars, based on 1 article reviews
matrix-assisted laser desorption/ionization time of flight mass spectrometry (maldi-tof ms) platform massarray tm - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
DNA Methylation Assay:Article Title: MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes Article Snippet: The DNA methylation status of miR-200f loci in tumor samples were inspected using Article Title: Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer Article Snippet: DNA methylation analysis were performed in the Sequenom MassArray® MALDI-TOF 42 platform, and we observed similar low methylation levels both in triple-negative (n=25) and 43 estrogen/progesterone receptor positive (n= 26) tumors. Article Title: MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes Article Snippet: We therefore evaluated the CpG methylation rates of the respective miR-200f promoter regions in our tumor series using the Methylation:Article Title: MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes Article Snippet: The DNA methylation status of miR-200f loci in tumor samples were inspected using Article Title: Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer Article Snippet: DNA methylation analysis were performed in the Sequenom MassArray® MALDI-TOF 42 platform, and we observed similar low methylation levels both in triple-negative (n=25) and 43 estrogen/progesterone receptor positive (n= 26) tumors. Article Title: MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes Article Snippet: We therefore evaluated the CpG methylation rates of the respective miR-200f promoter regions in our tumor series using the Expressing:Article Title: MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes Article Snippet: The DNA methylation status of miR-200f loci in tumor samples were inspected using Article Title: Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer Article Snippet: DNA methylation analysis were performed in the Sequenom MassArray® MALDI-TOF 42 platform, and we observed similar low methylation levels both in triple-negative (n=25) and 43 estrogen/progesterone receptor positive (n= 26) tumors. Article Title: MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes Article Snippet: We therefore evaluated the CpG methylation rates of the respective miR-200f promoter regions in our tumor series using the CpG Methylation Assay:Article Title: MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes Article Snippet: The DNA methylation status of miR-200f loci in tumor samples were inspected using Article Title: Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer Article Snippet: DNA methylation analysis were performed in the Sequenom MassArray® MALDI-TOF 42 platform, and we observed similar low methylation levels both in triple-negative (n=25) and 43 estrogen/progesterone receptor positive (n= 26) tumors. Article Title: MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes Article Snippet: We therefore evaluated the CpG methylation rates of the respective miR-200f promoter regions in our tumor series using the |
